The core activity of Sebia is the development and manufacture of diagnostic solutions, particularly in the field of laboratory diagnostics, with a focus on the development of instruments and tests for the detection of diseases such as hemoglobinopathies, autoimmune and infectious diseases, as well as rare diseases.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Devices for clinical diagnostic laboratories, from single instruments to Workcell configurations, for small and large sample volumes in capillary and gel electrophoresis as well as IFA and ELISA.
Tests
Diagnostic tests for multiple myeloma, metabolic disorders, hemoglobin disorders, autoimmune diseases and infectious diseases, with assays for capillary and gel electrophoresis as well as ELISA and SMC technology.
Software (PHORESIS)
Software for analyzing, managing, storing and retrieving Sebia assay results on electrophoresis instruments, with networking features, remote access and validation processes.
Sebia Lean Service
Modular service offering to improve laboratory efficiency with Lean assessment, solution dimensioning, solution integration, impact analysis and Lean transformation.
Sebia Academy
Continuing education program with scientific and medical content for customers, including upcoming events and on-demand webinars for technical staff and graduates.
Knowledge
No knowledge articles yet
Once SEBIA Swiss GmbH has claimed this profile, we'll publish editorial articles and case studies here together.